These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23196212)

  • 41. Cell cycle reentry and cell proliferation as candidates for the seizure predispositions in the hippocampus of EL mouse brain.
    Murashima YL; Suzuki J; Yoshii M
    Epilepsia; 2007; 48 Suppl 5():119-25. PubMed ID: 17910591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain uptake of diazepam and phenytoin in a genetic animal model of absence epilepsy.
    Nicolazzo JA; Steuten JA; Charman SA; Taylor N; Davies PJ; Petrou S
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):647-9. PubMed ID: 20082623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy.
    Citraro R; Russo E; Gratteri S; Di Paola ED; Ibbadu GF; Curinga C; Gitto R; Chimirri A; Donato G; De Sarro G
    Neuropharmacology; 2006 Nov; 51(6):1058-67. PubMed ID: 16901515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of the substantia nigra in GABA-mediated anticonvulsant actions.
    Gale K
    Adv Neurol; 1986; 44():343-64. PubMed ID: 3010676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The usefulness of olfactory bulb kindling as a model for evaluation of antiepileptics.
    Fujiwara A; Watanabe Y; Takechi K; Ishikawa T; Kaida Y; Akagi M; Kamei C
    Epilepsia; 2010 Mar; 51(3):445-53. PubMed ID: 19845738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppression of fully kindled seizure and retardation of kindling acquisition by YM928 in the rat kindling model of epilepsy.
    Yamashita H; Ohno K; Inami H; Shishikura J; Sakamoto S; Okada M; Yamaguchi T
    Eur J Pharmacol; 2004 Jun; 494(2-3):147-54. PubMed ID: 15212968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increase in drug-induced seizure susceptibility of transgenic mice overexpressing GABA transporter-1.
    Zhao WJ; Ma YH; Fei J; Mei ZT; Guo LH
    Acta Pharmacol Sin; 2003 Oct; 24(10):991-5. PubMed ID: 14531940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Valproate reduces spontaneous generalized spikes and waves but not photoparoxysmal reactions in patients with idiopathic generalized epilepsies.
    Muhle H; Ettle E; Boor R; Stephani U; Siniatchkin M
    Epilepsia; 2011 Jul; 52(7):1297-302. PubMed ID: 21480883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Seizure susceptibility alteration following reversible cholestasis in mice: Modulation by opioids and nitric oxide.
    Gholipour T; Riazi K; Noorian AR; Jannati A; Honar H; Doratotaj B; Nik HH; Shariftabrizi A; Dehpour AR
    Eur J Pharmacol; 2008 Feb; 580(3):322-8. PubMed ID: 18164287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Triheptanoin Mitigates Brain ATP Depletion and Mitochondrial Dysfunction in a Mouse Model of Alzheimer's Disease.
    Yuan X; Wang L; Tandon N; Sun H; Tian J; Du H; Pascual JM; Guo L
    J Alzheimers Dis; 2020; 78(1):425-437. PubMed ID: 33016909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments.
    Vezzani A; Wu HQ; Tullii M; Samanin R
    J Pharmacol Exp Ther; 1986 Oct; 239(1):256-63. PubMed ID: 2945004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation.
    Jones NC; Salzberg MR; Kumar G; Couper A; Morris MJ; O'Brien TJ
    Exp Neurol; 2008 Jan; 209(1):254-60. PubMed ID: 18022621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of N-hydroxymethyl-p-isopropoxyphenylsuccinimide on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Kominek M; Florek-Luszczki M; Tchaytchian DA; Kocharov SL; Zolkowska D
    Epilepsy Res; 2012 Jun; 100(1-2):27-36. PubMed ID: 22281062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil.
    Rundfeldt C; Wlaź P; Hönack D; Löscher W
    J Pharmacol Exp Ther; 1995 Nov; 275(2):693-702. PubMed ID: 7473156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic omega-3 supplementation in seizure-prone versus seizure-resistant rat strains: a cautionary tale.
    Gilby KL; Jans J; McIntyre DC
    Neuroscience; 2009 Oct; 163(3):750-8. PubMed ID: 19596053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alternative Fuels in Epilepsy and Amyotrophic Lateral Sclerosis.
    Tefera TW; Tan KN; McDonald TS; Borges K
    Neurochem Res; 2017 Jun; 42(6):1610-1620. PubMed ID: 27868154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
    Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS
    Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic and environmental interactions determine seizure susceptibility in epileptic EL mice.
    Todorova MT; Mantis JG; Le M; Kim CY; Seyfried TN
    Genes Brain Behav; 2006 Oct; 5(7):518-27. PubMed ID: 17010098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain.
    Marin-Valencia I; Good LB; Ma Q; Malloy CR; Pascual JM
    J Cereb Blood Flow Metab; 2013 Feb; 33(2):175-82. PubMed ID: 23072752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Central nervous system hyperexcitability associated with glutamate dehydrogenase gain of function mutations.
    Raizen DM; Brooks-Kayal A; Steinkrauss L; Tennekoon GI; Stanley CA; Kelly A
    J Pediatr; 2005 Mar; 146(3):388-94. PubMed ID: 15756227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.